XTalks

SEPTEMBER 23, 2020

Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. These are important feature innovations for those that depend on insulin injections.

Insulin 98

Insulin Marketing Drug Delivery Compliance 98

pharmaphorum

FEBRUARY 3, 2022

There is a rising demand for vaccines, insulin, and many modern medicines used to treat cancer and other chronic diseases. As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drug delivery and prefilled syringe market in the coming years.

Drug Delivery 52

Drug Delivery Drugs Engineer Scientist 52

XTalks

FEBRUARY 24, 2021

The injection experience is an often-overlooked aspect in insulin administration. For many daily insulin users, the experience is an important one, as it is directly related to quality of life and medication compliance. Traditional needles on the market range between 8 and 12.5

Insulin 64

Insulin Production Drug Delivery Marketing 64

Roots Analysis

MARCH 21, 2022

However, several drug delivery devices that enable patients to self-administer their respective medications are now available. Subcutaneous biologics – current market landscape. Subcutaneous drug delivery systems – the helping hand for patients. Of these, 50 players have approved subcutaneous biologics.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Antibody Marketing 52

Roots Analysis

FEBRUARY 22, 2022

Autoinjector As Emerging Drug Delivery Device. One of the most widely recognized autoinjector in the market is EpiPen® (Mylan), which is a prefilled epinephrine autoinjector. The market landscape is predominantly characterized by the presence of several small and mid-sized companies with a few established players.

Drug Delivery 52

Drug Delivery Production Marketing Development 52

Camargo

OCTOBER 14, 2020

The FDA is planning two listening sessions to allow manufacturers, developers, health care providers, researchers, and other interested parties to learn more about the purpose and function of the DHCoE. Approval of the Month: FDA Approves First Closed-Loop Monitoring and Drug Delivery Device.

Development 196

Development Insulin Drug Delivery Production 196

Roots Analysis

SEPTEMBER 22, 2023

These innovative instruments combine precision, convenience, and patient-centered design to revolutionize drug delivery. These significant benefits offered by wearable injectors, coupled with their rising demand in the pharmaceutical industry and healthcare sector, worldwide is likely to drive market growth during in the coming years.

Drug Delivery 40

Drug Delivery Marketing Insulin Manufacturing 40